Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. | 451,449 | reported | 12 Feb 2024 | tx 60+741,899−116,103 |
| Nautilus Biotechnology, Inc. | 45,000 | reported | 23 Jun 2025 | tx 4+221,467 |
| Roivant Sciences Ltd. | 15,804 | reported | 16 Mar 2026 | tx 24+339,059−48,124 |
| Kinnate Biopharma Inc. | 0 | reported | 03 Apr 2024 | tx 7+65,500−126,251 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Mar 2026 | SALE | Roivant Sciences Ltd. | 41,861 | 28.68 USD | |
| 20 Jan 2026 | TAX_WITHHOLDING | Roivant Sciences Ltd. | 54 | 22.98 USD | |
| 20 Jan 2026 | GRANT_AWARD | Roivant Sciences Ltd. | 815 | 0.00 USD | |
| 20 Oct 2025 | GRANT_AWARD | Roivant Sciences Ltd. | 1,056 | 0.00 USD | |
| 10 Sept 2025 | OTHER | Roivant Sciences Ltd. | 1,661 | 13.77 USD | |
| 10 Sept 2025 | GRANT_AWARD | Roivant Sciences Ltd. | 14,524 | 0.00 USD | |
| 10 Sept 2025 | GRANT_AWARD | Roivant Sciences Ltd. | 33,726 | 0.00 USD | deriv |
| 17 Jul 2025 | GRANT_AWARD | Roivant Sciences Ltd. | 1,609 | 0.00 USD | |
| 23 Jun 2025 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 45,000 | 0.00 USD | deriv |
| 17 Apr 2025 | GRANT_AWARD | Roivant Sciences Ltd. | 1,847 | 0.00 USD | |
| 23 Jan 2025 | TAX_WITHHOLDING | Roivant Sciences Ltd. | 180 | 11.21 USD | |
| 23 Jan 2025 | GRANT_AWARD | Roivant Sciences Ltd. | 1,672 | 0.00 USD | |
| 21 Oct 2024 | GRANT_AWARD | Roivant Sciences Ltd. | 1,613 | 0.00 USD | |
| 12 Sept 2024 | OTHER | Roivant Sciences Ltd. | 4,245 | 12.12 USD | |
| 10 Sept 2024 | GRANT_AWARD | Roivant Sciences Ltd. | 16,406 | 0.00 USD | |
| 10 Sept 2024 | GRANT_AWARD | Roivant Sciences Ltd. | 27,894 | 0.00 USD | deriv |
| 23 Jul 2024 | GRANT_AWARD | Roivant Sciences Ltd. | 1,702 | 0.00 USD | |
| 14 Jun 2024 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 45,000 | 0.00 USD | deriv |
| 24 Apr 2024 | GRANT_AWARD | Roivant Sciences Ltd. | 1,146 | 0.00 USD | |
| 24 Apr 2024 | TAX_WITHHOLDING | Roivant Sciences Ltd. | 123 | 10.90 USD | |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 60,751 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 20,250 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 25,000 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 20,250 | — | deriv |
| 12 Feb 2024 | SALE | Zentalis Pharmaceuticals, Inc. | 2,573 | 11.44 USD |
1 purchase reported after at least 12 months of silence — most recent on 18 Aug 2021.